ArticleMultiple sclerosis journal - experimental, translational and clinical
Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programme.
T A Hardy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.